Dysglycemia, Not Altered Sex Steroid Hormones, Affects Cognitive Function in Polycystic Ovary Syndrome

Brittany Y Jarrett; Natalie Vantman; Reid J Mergler; Eric D Brooks; Roger A Pierson; Donna R Chizen; Marla E Lujan

doi:10.1210/js.2019-00112

Dysglycemia, Not Altered Sex Steroid Hormones, Affects Cognitive Function in Polycystic Ovary Syndrome

J Endocr Soc. 2019 Jul 30;3(10):1858-1868. doi: 10.1210/js.2019-00112. eCollection 2019 Oct 1.

Authors

Brittany Y Jarrett¹, Natalie Vantman¹, Reid J Mergler¹, Eric D Brooks¹, Roger A Pierson², Donna R Chizen², Marla E Lujan¹

Affiliations

¹ Division of Nutritional Sciences, Cornell University, Ithaca, New York.
² Department of Obstetrics and Gynecology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

Abstract

Context: Polycystic ovary syndrome (PCOS) is a complex endocrine condition characterized by multiple reproductive and metabolic abnormalities. Because individual reproductive and metabolic abnormalities modulate working memory in the general population, there is growing interest in whether cognitive function is dually and negatively affected in PCOS.

Objective: To examine the association of reproductive and metabolic features with cognitive function in women with and without PCOS.

Design: An observational, cross-sectional study was conducted at an academic clinical research center in North America between 2006 and 2009. Common tests of working memory (i.e., manual dexterity, perceptual speed, and visuospatial ability) were performed by women with PCOS (n = 40) and control subjects (n = 40). Markers of sex steroid hormones, ovulatory function, and cardiometabolic health were also assessed.

Results: Reduced visuospatial ability was observed in women with PCOS compared with control subjects (P < 0.01). Reduced visuospatial ability was linked to higher levels of hemoglobin A1c in the entire study cohort, independent of body mass index or PCOS status. No associations were observed between visuospatial ability and reproductive features, after controlling for confounding variables.

Conclusion: Our findings support a role for glycemic control, and not PCOS per se, in cognitive dysfunction in women of reproductive age. Additional studies are needed to understand the short- and long-term effects of dysglycemia on brain health in women with PCOS, given their increased propensity for metabolic comorbidities, compared with control subjects.

Keywords: androgens; cognition; glycated hemoglobin A; polycystic ovary syndrome.